DBRC
AIM

D.B. Root & Company’s AIM ImmunoTech AIM Stock Holding History

D.B. Root & Company’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-121
Closed -$1.47K – 204
2025
Q1 		$1.47K Hold
121
– – ﹤0.01% 181
2024
Q4 		$2.39K Hold
121
– – ﹤0.01% 184
2024
Q3 		$3.25K Hold
121
– – ﹤0.01% 179
2024
Q2 		$4.49K Hold
121
– – ﹤0.01% 184
2024
Q1 		$5.68K Hold
121
– – ﹤0.01% 176
2023
Q4 		$5.3K Hold
121
– – ﹤0.01% 165
2023
Q3 		$5.48K Hold
121
– – ﹤0.01% 165
2023
Q2 		$8.07K Buy
+121
New +$5.84K ﹤0.01% 169

Other funds holding AIM

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

D.B. Root & Company's AIM Position: Q2 2025 in Review

D.B. Root & Company sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 121 shares — an estimated $1.47K sold.

D.B. Root & Company first reported a position in AIM in Q2 2023 and held it in 8 quarters. The position peaked at $8.07K in Q2 2023. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • D.B. Root & Company reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • D.B. Root & Company sold 121 AIM ImmunoTech shares in Q2 2025, an estimated $1.47K.
  • D.B. Root & Company first reported a position in AIM ImmunoTech in Q2 2023 and held it in 8 quarters.
  • D.B. Root & Company's AIM ImmunoTech position peaked at $8.07K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on D.B. Root & Company's 13F filing for Q2 2025, filed 22 Jul 2025.